RPL22L1 and colorectal carcinoma: Moreover, when RPL22L1 induction is considered together with alterations in DNA repair enzymes (MGMT and MLH1) modulated by RPL22L1, its prognostic value becomes even clearer, as CRC patients exhibiting these alterations exhibit significantly reduced OS.